Search Results - "Powderly J"

Panax notoginseng Saponins Enhance Chemotherapy Carboplatin and Immune Checkpoint Blockades PD1ab by Modulating SERPINE1 Downregulation in LUAD.

Authors: Wang, Yuhuai Wang, Ping Liu, Jiaqi et al.

Source: Pharmacognosy Magazine. Jun2026, Vol. 22 Issue 2, p605-615. 11p.

Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal–Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities.

Authors: Paniagua-Herranz, Lucía Doger, Bernard Díaz-Tejeiro, Cristina et al.

Source: Cancers. Jun2023, Vol. 15 Issue 12, p3250. 13p.

Impact of Prior mRNA COVID-19 Vaccination on PFS2 in NSCLC Patients Receiving Second-Line Immune Checkpoint Inhibitors: A Real-World Analysis.

Authors: Çelik, Selahattin Kavak, Engin Eren Zeynelgil, Esra et al.

Source: Journal of Clinical Medicine. Apr2026, Vol. 15 Issue 7, p2475. 14p.

First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti-PD-1 antibody budigalimab in patients with advanced solid tumors.

Authors: Shimizu T Powderly J Abdul Razak A et al.

Source: Frontiers in oncology [Front Oncol] 2024 Oct 29; Vol. 14, pp. 1376551. Date of Electronic Publication: 2024 Oct 29 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Mechanism of Non–Small Cell Lung Cancer–Derived Extracellular Vesicle miRNA hsa‐let‐7b‐5p Targeting AP1S1 to Regulate M2 Macrophage Polarization.

Authors: Liu, Lijuan Kou, Zixing Wang, Tianhua et al.

Source: International Journal of Genomics. 1/17/2026, Vol. 2026, p1-22. 22p.

Impact of the PD-1/PD-L1 inhibitor SCL-1 on MDA-MB231 tumor growth in a humanized MHC-double knockout NOG mouse model.

Authors: Ikeya, Tomoatsu Ashizawa, Tadashi Kanematsu, Akari et al.

Source: Scientific Reports. 7/24/2025, Vol. 15 Issue 1, p1-11. 11p.

Author Index.

Source: Asia Pacific Journal of Clinical Oncology. Dec2014 Supplement, Vol. 10, p211-217. 7p.

Identification of lung squamous cell carcinoma subtypes based on STING pathway expression and validation of prognostic features.

Authors: Liu, Wenjun Cheng, Dezhong

Source: Nucleosides, Nucleotides & Nucleic Acids. 2026, Vol. 45 Issue 5, p482-499. 18p.

Adenosine Signaling as a Central Integrative Network in Cellular Stress Responses and a Therapeutically Actionable Target in Human Disease.

Authors: Satyam, Shakta Mani El-Tanani, Mohamed Alghoul, Wasim Iyad et al.

Source: Biomolecules (2218-273X). May2026, Vol. 16 Issue 5, p732. 26p.

Ultrasound‐Stimulated Microbubble Cavitation Combined With Anti‐PD‐L1 Blockade Inhibits the Progression of MC38 Tumors and Alters the Composition of Gut Microbiota in Mice.

Authors: Li, Hui Yang, Guoliang Yang, Jun et al.

Source: International Journal of Microbiology. 10/17/2025, Vol. 2025, p1-37. 37p.

Piezo1 Activation Improves NSCLC Liver Metastasis Immunotherapy by Overriding Matrix Stiffness‐Mediated Bimodal PD‐L1/CXCL10 Regulation.

Authors: Zhang, Tian Li, Yuan Cheng, Bo et al.

Source: Advanced Science. 8/28/2025, Vol. 12 Issue 32, p1-16. 16p.

Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma.

Authors: Fröhlich, Fabienne Ramelyte, Egle Turko, Patrick et al.

Source: Cancers. Aug2023, Vol. 15 Issue 15, p3818. 11p.

Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies.

Authors: Cheng, Kexuan Guo, Jiazheng Li, Yating et al.

Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 11, p5068. 16p.

Multi-omics analysis reveals immunosuppression in oesophageal squamous cell carcinoma induced by creatine accumulation and HK3 deficiency.

Authors: Gao, Yingzhen He, Siyu Meng, Xiaoyan et al.

Source: Genome Medicine. 5/6/2025, Vol. 17 Issue 1, p1-25. 25p.

The Emerging Melanoma Management: Historical Perspective to Future Directions.

Authors: Hui, Shin Yee Jain, Rohit Haass, Nikolas K. et al.

Source: Cancers. Mar2026, Vol. 18 Issue 6, p968. 20p.

The JAK/STAT Pathway in Cancer: From Molecular Mechanisms to Clinical Applications.

Authors: Liao, Yixing Wei, Qi Song, Hongjun et al.

Source: Medcomm: Oncology. Mar2026, Vol. 5 Issue 1, p1-28. 28p.

Next‐Generation Immune Checkpoints and Tumor Microenvironment Modulation in Cancer Immunotherapy.

Authors: Bautista, Jhommara Echeverría, Carolina E. Maldonado-Noboa, Iván et al.

Source: Journal of Immunology Research. 2/16/2026, Vol. 2026, p1-20. 20p.

Prognostic and therapeutic roles of B7-H3 and B7-H4 in prostate cancer.

Authors: Hu Y Yang W Guo S et al.

Source: Discover oncology [Discov Oncol] 2026 Apr 19; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 19.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

m⁶A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma.

Authors: Fang, Han Sun, Qi Zhou, Jin et al.

Source: Molecular Cancer. 6/23/2023, Vol. 22 Issue 1, p1-16. 16p.

State of the Art of Immune Checkpoint Inhibitors in Unresectable Pancreatic Cancer: A Comprehensive Systematic Review.

Authors: Orlandi, Elena Guasconi, Massimo Romboli, Andrea et al.

Source: International Journal of Molecular Sciences. Mar2025, Vol. 26 Issue 6, p2620. 21p.